A Case of Diabetic Ketoacidosis in a Patient on an SGLT2 Inhibitor and a Ketogenic Diet: A Critical Trio Not to Be Missed

Results from major clinical trials have shown significant cardiorenal-protective benefits of SGLT2 inhibitors in patients with type 2 diabetes (T2DM), leading to increased popularity. A rare but serious side effect of SGLT2 inhibitors is euglycemic diabetic ketoacidosis (EDKA), which presents more c...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinmetz-Wood, Samantha, Gilbert, Matthew, Menson, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443033/
https://www.ncbi.nlm.nih.gov/pubmed/32855828
http://dx.doi.org/10.1155/2020/8832833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443033/
https://www.ncbi.nlm.nih.gov/pubmed/32855828
http://dx.doi.org/10.1155/2020/8832833

Ejemplares similares